228 related articles for article (PubMed ID: 35640075)
1. Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update.
Ramakrishna N; Anders CK; Lin NU; Morikawa A; Temin S; Chandarlapaty S; Crews JR; Davidson NE; Franzoi MAB; Kirshner JJ; Krop IE; Patt DA; Perlmutter J; Giordano SH
J Clin Oncol; 2022 Aug; 40(23):2636-2655. PubMed ID: 35640075
[TBL] [Abstract][Full Text] [Related]
2. Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
Ramakrishna N; Temin S; Chandarlapaty S; Crews JR; Davidson NE; Esteva FJ; Giordano SH; Kirshner JJ; Krop IE; Levinson J; Modi S; Patt DA; Perlmutter J; Winer EP; Lin NU
J Clin Oncol; 2018 Sep; 36(27):2804-2807. PubMed ID: 29939840
[TBL] [Abstract][Full Text] [Related]
3. Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.
Ramakrishna N; Temin S; Chandarlapaty S; Crews JR; Davidson NE; Esteva FJ; Giordano SH; Gonzalez-Angulo AM; Kirshner JJ; Krop I; Levinson J; Modi S; Patt DA; Perez EA; Perlmutter J; Winer EP; Lin NU
J Clin Oncol; 2014 Jul; 32(19):2100-8. PubMed ID: 24799487
[TBL] [Abstract][Full Text] [Related]
4. Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update.
Giordano SH; Franzoi MAB; Temin S; Anders CK; Chandarlapaty S; Crews JR; Kirshner JJ; Krop IE; Lin NU; Morikawa A; Patt DA; Perlmutter J; Ramakrishna N; Davidson NE
J Clin Oncol; 2022 Aug; 40(23):2612-2635. PubMed ID: 35640077
[TBL] [Abstract][Full Text] [Related]
5. Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update.
Giordano SH; Temin S; Chandarlapaty S; Crews JR; Esteva FJ; Kirshner JJ; Krop IE; Levinson J; Lin NU; Modi S; Patt DA; Perlmutter J; Ramakrishna N; Winer EP; Davidson NE
J Clin Oncol; 2018 Sep; 36(26):2736-2740. PubMed ID: 29939838
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases.
Leyland-Jones B
J Clin Oncol; 2009 Nov; 27(31):5278-86. PubMed ID: 19770385
[TBL] [Abstract][Full Text] [Related]
7. How we treat HER2-positive brain metastases.
Stavrou E; Winer EP; Lin NU
ESMO Open; 2021 Oct; 6(5):100256. PubMed ID: 34482180
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
Parsai S; Miller JA; Juloori A; Chao ST; Kotecha R; Mohammadi AM; Ahluwalia MS; Murphy ES; Barnett GH; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
J Neurosurg; 2019 Feb; 132(2):503-511. PubMed ID: 30738402
[TBL] [Abstract][Full Text] [Related]
9. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
Vogelbaum MA; Brown PD; Messersmith H; Brastianos PK; Burri S; Cahill D; Dunn IF; Gaspar LE; Gatson NTN; Gondi V; Jordan JT; Lassman AB; Maues J; Mohile N; Redjal N; Stevens G; Sulman E; van den Bent M; Wallace HJ; Weinberg JS; Zadeh G; Schiff D
J Clin Oncol; 2022 Feb; 40(5):492-516. PubMed ID: 34932393
[TBL] [Abstract][Full Text] [Related]
10. Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Chao ST; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
Cancer; 2017 Jun; 123(12):2283-2293. PubMed ID: 28192598
[TBL] [Abstract][Full Text] [Related]
11. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.
Kuba S; Ishida M; Nakamura Y; Yamanouchi K; Minami S; Taguchi K; Eguchi S; Ohno S
Jpn J Clin Oncol; 2014 Nov; 44(11):1025-31. PubMed ID: 25156682
[TBL] [Abstract][Full Text] [Related]
12. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline.
Schiff D; Messersmith H; Brastianos PK; Brown PD; Burri S; Dunn IF; Gaspar LE; Gondi V; Jordan JT; Maues J; Mohile N; Redjal N; Stevens GHJ; Sulman EP; van den Bent M; Wallace HJ; Zadeh G; Vogelbaum MA
J Clin Oncol; 2022 Jul; 40(20):2271-2276. PubMed ID: 35561283
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
Korde LA; Somerfield MR; Carey LA; Crews JR; Denduluri N; Hwang ES; Khan SA; Loibl S; Morris EA; Perez A; Regan MM; Spears PA; Sudheendra PK; Symmans WF; Yung RL; Harvey BE; Hershman DL
J Clin Oncol; 2021 May; 39(13):1485-1505. PubMed ID: 33507815
[TBL] [Abstract][Full Text] [Related]
14. Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
Freedman RA; Gelman RS; Wefel JS; Melisko ME; Hess KR; Connolly RM; Van Poznak CH; Niravath PA; Puhalla SL; Ibrahim N; Blackwell KL; Moy B; Herold C; Liu MC; Lowe A; Agar NY; Ryabin N; Farooq S; Lawler E; Rimawi MF; Krop IE; Wolff AC; Winer EP; Lin NU
J Clin Oncol; 2016 Mar; 34(9):945-52. PubMed ID: 26834058
[TBL] [Abstract][Full Text] [Related]
15. Narrative Review of Multidisciplinary Management of Central Nervous Involvement in Patients with HER2-Positive Metastatic Breast Cancer: Focus on Elderly Patients.
Galve-Calvo E; Alonso-Babarro A; Martínez-García M; Pi-Figueras M; Villalba G; Alonso S; Contreras J
Adv Ther; 2023 Aug; 40(8):3304-3331. PubMed ID: 37291377
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.
Giordano SH; Temin S; Kirshner JJ; Chandarlapaty S; Crews JR; Davidson NE; Esteva FJ; Gonzalez-Angulo AM; Krop I; Levinson J; Lin NU; Modi S; Patt DA; Perez EA; Perlmutter J; Ramakrishna N; Winer EP;
J Clin Oncol; 2014 Jul; 32(19):2078-99. PubMed ID: 24799465
[TBL] [Abstract][Full Text] [Related]
17. CNS metastases in breast cancer.
Lin NU; Bellon JR; Winer EP
J Clin Oncol; 2004 Sep; 22(17):3608-17. PubMed ID: 15337811
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
Larsen PB; Kümler I; Nielsen DL
Cancer Treat Rev; 2013 Nov; 39(7):720-7. PubMed ID: 23481218
[TBL] [Abstract][Full Text] [Related]
19. New target therapies for brain metastases from breast cancer.
Metro G; Fabi A
Curr Cancer Drug Targets; 2012 Mar; 12(3):210-7. PubMed ID: 22268385
[TBL] [Abstract][Full Text] [Related]
20. Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.
Dawood S; Gonzalez-Angulo AM
Oncologist; 2013 Jun; 18(6):675-84. PubMed ID: 23740934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
